Precigen, Inc. (PGEN) compared with its closest peers (CTNM, CRBU, RLAY, CATX, PRLD). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Contineum Therapeutics, Relay Therapeutics, Perspective Therapeutics, Prelude Therapeutics, Fate Therapeutics, Crescent Biopharma, Crinetics Pharmaceuticals, Kyverna Therapeutics and X4 Pharmaceuticals share Precigen's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $554.52M | — |
| Caribou Biosciences, Inc. (CRBU) | $137.23M | — |
| Relay Therapeutics, Inc. (RLAY) | $4.13B | — |
| Perspective Therapeutics, Inc. (CATX) | $321.91M | — |
| Prelude Therapeutics Incorporated (PRLD) | $366.30M | — |
| Fate Therapeutics, Inc. (FATE) | $277.98M | — |
| Crescent Biopharma, Inc. (CBIO) | $717.99M | — |
| Crinetics Pharmaceuticals, Inc. (CRNX) | $9.01B | — |
| Kyverna Therapeutics, Inc. (KYTX) | $448.98M | — |
| X4 Pharmaceuticals, Inc. (XFOR) | $330.12M | — |
| Sector P/E (Healthcare) | 19.4 |
| Industry P/E (Pharmaceutical Products) | 15.1 |
PGEN overview · PGEN earnings · PGEN financials · PGEN KPIs · PGEN documents · PGEN ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.